A study in Cell Discovery shows the ketogenic diet increases brain GABA levels and the GABA/glutamate ratio through β-hydroxybutyric acid, offering a potential mechanism for its effectiveness in reducing epilepsy seizures.
Data Insights – Pharmaceutical Technology
By Company Name No Filter Selected Bristol-Myers Squibb (339) Merck (278) Pfizer (248) Novartis (244) AstraZeneca (221) F. Hoffmann-La Roche (180) AbbVie (163) BeiGene (137)